$XPL
Solitario Resources Corp

2023 Q4 Form 10-Q Financial Statement

#000165495423013940 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $639.0K $282.0K
YoY Change 144.83% -35.17%
% of Gross Profit
Research & Development $630.0K $918.0K
YoY Change 39.69% 40.15%
% of Gross Profit
Depreciation & Amortization $6.000K $7.000K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.275M $1.207M
YoY Change 77.58% 10.03%
Operating Profit
YoY Change
Interest Expense $233.0K -$85.00K
YoY Change 482.5% -302.38%
% of Operating Profit
Other Income/Expense, Net $0.00 -$85.00K
YoY Change -100.0% -312.5%
Pretax Income -$1.042M -$1.292M
YoY Change 56.46% 22.23%
Income Tax
% Of Pretax Income
Net Earnings -$1.042M -$1.292M
YoY Change 56.46% 22.23%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 79.09M shares 69.52M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.232M $5.042M
YoY Change -2.61% 321.22%
Cash & Equivalents $200.0K $168.0K
Short-Term Investments $1.032M $4.874M
Other Short-Term Assets $273.0K $237.0K
YoY Change 618.42% 540.54%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.941M $5.279M
YoY Change 89.21% -13.91%
LONG-TERM ASSETS
Property, Plant & Equipment $16.81M $16.83M
YoY Change 0.21% -0.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.000K $4.000K
YoY Change -97.01% -97.32%
Total Long-Term Assets $16.82M $16.83M
YoY Change 0.21% -0.05%
TOTAL ASSETS
Total Short-Term Assets $9.941M $5.279M
Total Long-Term Assets $16.82M $16.83M
Total Assets $26.76M $22.11M
YoY Change 21.44% -3.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $593.0K $295.0K
YoY Change 160.09% -47.97%
Accrued Expenses $39.00K $31.00K
YoY Change 11.43% -26.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $632.0K $327.0K
YoY Change 140.3% -46.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $175.0K $185.0K
YoY Change 40.0% 43.41%
Total Long-Term Liabilities $175.0K $185.0K
YoY Change 40.0% 43.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $632.0K $327.0K
Total Long-Term Liabilities $175.0K $185.0K
Total Liabilities $807.0K $512.0K
YoY Change 107.99% -30.62%
SHAREHOLDERS EQUITY
Retained Earnings -$57.64M -$56.60M
YoY Change 6.97% 6.35%
Common Stock $796.0K $692.0K
YoY Change 22.84% 6.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.95M $21.60M
YoY Change
Total Liabilities & Shareholders Equity $26.76M $22.11M
YoY Change 21.44% -3.75%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.042M -$1.292M
YoY Change 56.46% 22.23%
Depreciation, Depletion And Amortization $6.000K $7.000K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$579.0K -$919.0K
YoY Change -39.18% 35.95%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K $3.000K
YoY Change -97.78% -100.8%
Acquisitions
YoY Change
Other Investing Activities -$4.465M -$1.873M
YoY Change -560.78% -297.16%
Cash From Investing Activities -$4.464M -$1.876M
YoY Change -540.24% -426.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.075M 2.467M
YoY Change 50650.0%
NET CHANGE
Cash From Operating Activities -579.0K -919.0K
Cash From Investing Activities -4.464M -1.876M
Cash From Financing Activities 5.075M 2.467M
Net Change In Cash 32.00K -328.0K
YoY Change -55.56% 221.57%
FREE CASH FLOW
Cash From Operating Activities -$579.0K -$919.0K
Capital Expenditures -$1.000K $3.000K
Free Cash Flow -$578.0K -$922.0K
YoY Change -36.27% 207.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5254000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2022Q4 us-gaap Assets
Assets
22034000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
228000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000917225
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64801373 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69163040 shares
xpl Non Cash Lease Amortization Of Right Of Use Lease Asset Expense Recognized
NonCashLeaseAmortizationOfRightOfUseLeaseAssetExpenseRecognized
29000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SOLITARIO RESOURCES CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1285791
dei Entity Address Address Line1
EntityAddressAddressLine1
4251 Kipling St. Suite 390
dei Entity Address City Or Town
EntityAddressCityOrTown
Wheat Ridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80033
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
534-1030
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
XPL
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79086358 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
3964000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
3951000 usd
CY2023Q3 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
910000 usd
CY2022Q4 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
949000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
237000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
5279000 usd
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
186000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
134000 usd
CY2023Q3 us-gaap Assets
Assets
22111000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
295000 usd
CY2023Q3 xpl Kinross Call Option Current
KinrossCallOptionCurrent
1000 usd
CY2022Q4 xpl Kinross Call Option Current
KinrossCallOptionCurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
31000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
327000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
263000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
185000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
125000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69163040 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64801373 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
692000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
648000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
77507000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74886000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56600000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53888000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
21599000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21646000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22111000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22034000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
918000 usd
CY2022Q3 us-gaap Exploration Expense
ExplorationExpense
655000 usd
us-gaap Exploration Expense
ExplorationExpense
1748000 usd
us-gaap Exploration Expense
ExplorationExpense
1832000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
23000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
282000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
435000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1073000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1099000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1207000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1097000 usd
us-gaap Operating Expenses
OperatingExpenses
2840000 usd
us-gaap Operating Expenses
OperatingExpenses
2954000 usd
CY2023Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
35000 usd
CY2022Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
29000 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
88000 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
97000 usd
CY2023Q3 us-gaap Other Income
OtherIncome
0 usd
CY2022Q3 us-gaap Other Income
OtherIncome
20000 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
20000 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
7000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
30000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4000 usd
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2022Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-159000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-22000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
49000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-120000 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-141000 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
13000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-39000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-142000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-85000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
40000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-308000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1292000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1057000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2712000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3262000 usd
CY2023Q3 xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.02
CY2022Q3 xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.02
xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.04
xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.05
CY2023Q3 xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67752000 shares
CY2022Q3 xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
64769000 shares
xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67625000 shares
xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
64091000 shares
us-gaap Profit Loss
ProfitLoss
-2712000 usd
us-gaap Profit Loss
ProfitLoss
-3262000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
23000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-39000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-142000 usd
xpl Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
49000 usd
xpl Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
120000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
184000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
271000 usd
xpl Loss On Sale Of Marketable Equity Securities
LossOnSaleOfMarketableEquitySecurities
0 usd
xpl Loss On Sale Of Marketable Equity Securities
LossOnSaleOfMarketableEquitySecurities
159000 usd
xpl Gain Loss On Derivative Instruments
GainLossOnDerivativeInstruments
30000 usd
xpl Gain Loss On Derivative Instruments
GainLossOnDerivativeInstruments
-4000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
199000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-266000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
299000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2684000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1948000 usd
xpl Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
36000 usd
xpl Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
69000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
386000 usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
12000 usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
49000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
53000 usd
xpl Sale Of Derivative Instruments Net
SaleOfDerivativeInstrumentsNet
31000 usd
xpl Sale Of Derivative Instruments Net
SaleOfDerivativeInstrumentsNet
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
55000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-313000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2422000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2023000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2481000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2043000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-148000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-218000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
462000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244000 usd
xpl Acquisition Of Right To Use Asset
AcquisitionOfRightToUseAsset
87000 usd
xpl Acquisition Of Right To Use Asset
AcquisitionOfRightToUseAsset
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Solitario is subject to various risks and uncertainties that are specific to the nature of its business and the exploration of its mineral properties. Solitario also faces various macro risks and uncertainties, such as risks related to health epidemics, pandemics, and other outbreaks or resurgences of communicable diseases, the occurrence of natural disasters, rising geopolitical tension and instability, acts of war or terrorism, global economic uncertainty, inflationary pressures, increased interest rates, and volatility and disruption in national and international financial markets. These risks and uncertainties could significantly disrupt Solitario’s operations and may materially and adversely affect its business and financial condition. Certain of these risks and uncertainties are discussed under the heading “Risk Factors” in Item 1A of our 2022 Annual Report and under the heading “Forward-Looking Statements” in Item 2(l) of Part I of this report. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Solitario will continue taking proactive steps to monitor and address the impacts of these risks and uncertainties on its operations, financial condition, and liquidity. Such steps may include, for example, modifying the scope of exploration projects to the extent necessary to respond to public-health emergencies, a step Solitario and its joint venture partners took to address the impacts of the COVID-19 pandemic; reducing costs and increasing operational efficiency in response to inflationary stress and economic downturn; and performing ongoing evaluations of the potential impacts of market volatility, general economic uncertainty, and rising geopolitical tension on Solitario’s ability to access future traditional funding sources on the same or reasonably similar terms as in past periods.  While Solitario will continue to monitor and address the effects of these risks and uncertainties, the extent to which they ultimately impact Solitario’s business, including its exploration and other activities and the market for its securities, will depend on future developments, which are highly uncertain and cannot be predicted at this time.</p>
CY2023Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
82000 usd
CY2023Q3 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
1391000 usd
xpl Maturities Period Of Current Assets In United States Treasury Securities
MaturitiesPeriodOfCurrentAssetsInUnitedStatesTreasurySecurities
2,573,000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5195000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5390000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5513000 shares
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
918000 usd
CY2022Q3 us-gaap Exploration Expense
ExplorationExpense
655000 usd
us-gaap Exploration Expense
ExplorationExpense
1748000 usd
us-gaap Exploration Expense
ExplorationExpense
1832000 usd
CY2023Q3 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
910000 usd
CY2022Q4 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
949000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1440000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1440000 usd
CY2023Q3 xpl Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-530000 usd
CY2022Q4 xpl Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-491000 usd
CY2023Q3 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
910000 usd
CY2022Q4 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
949000 usd
CY2023Q3 xpl Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
0 usd
CY2022Q3 xpl Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
0 usd
xpl Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
0 usd
xpl Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
212000 usd
CY2023Q3 xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
0 usd
CY2022Q3 xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
0 usd
xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
0 usd
xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
-159000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0 usd
CY2022Q3 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
53000 usd
CY2023Q3 xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-141000 usd
CY2022Q3 xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
13000 usd
xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-39000 usd
xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-301000 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-141000 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
13000 usd
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-39000 usd
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-354000 usd
CY2023Q3 xpl Unrealized Gain On Marketable Equity Securities
UnrealizedGainOnMarketableEquitySecurities
-141000 usd
CY2022Q3 xpl Unrealized Gain On Marketable Equity Securities
UnrealizedGainOnMarketableEquitySecurities
13000 usd
xpl Unrealized Gain On Marketable Equity Securities
UnrealizedGainOnMarketableEquitySecurities
-39000 usd
xpl Unrealized Gain On Marketable Equity Securities
UnrealizedGainOnMarketableEquitySecurities
-142000 usd
CY2023Q3 xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
0 usd
CY2022Q3 xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
0 usd
xpl Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
-159000 usd
CY2023Q3 xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-141000 usd
CY2022Q3 xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
13000 usd
xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-39000 usd
xpl Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
-301000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
11000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
33000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
11000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
29000 usd
CY2023Q3 xpl Non Cash Lease Amortization Of Right Of Use Lease Asset Expense Recognized
NonCashLeaseAmortizationOfRightOfUseLeaseAssetExpenseRecognized
10000 usd
CY2022Q3 xpl Non Cash Lease Amortization Of Right Of Use Lease Asset Expense Recognized
NonCashLeaseAmortizationOfRightOfUseLeaseAssetExpenseRecognized
10000 usd
xpl Non Cash Lease Amortization Of Right Of Use Lease Asset Expense Recognized
NonCashLeaseAmortizationOfRightOfUseLeaseAssetExpenseRecognized
30000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
45000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
101000 usd
CY2023Q3 us-gaap Interest Portion Of Minimum Lease Payments Sale Leaseback Transactions
InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions
10000 usd
CY2023Q3 xpl Present Value Of Leases Payments
PresentValueOfLeasesPayments
91000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
186000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
134000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
3964000 usd
CY2023Q3 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
910000 usd
CY2023Q3 xpl Kinross Call Option Current
KinrossCallOptionCurrent
1000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
3951000 usd
CY2022Q4 xpl Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
949000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
434000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P23M
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21646000 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
67000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-380000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21333000 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
59000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1040000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20366000 usd
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
58000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2422000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1292000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
21599000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23183000 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13000 usd
CY2022Q1 xpl Issuance Of Shares At Net Value
IssuanceOfSharesAtNetValue
2023000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-514000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
24724000 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1691000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23047000 usd
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
245000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1057000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
22235000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
xpl-20230930_def.xml Edgar Link unprocessable
xpl-20230930_lab.xml Edgar Link unprocessable
0001654954-23-013940-index-headers.html Edgar Link pending
0001654954-23-013940-index.html Edgar Link pending
0001654954-23-013940.txt Edgar Link pending
0001654954-23-013940-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xpl-20230930.xsd Edgar Link pending
xpl_10q.htm Edgar Link pending
xpl_ex311.htm Edgar Link pending
xpl_ex312.htm Edgar Link pending
xpl_ex321.htm Edgar Link pending
xpl_10q_htm.xml Edgar Link completed
xpl-20230930_cal.xml Edgar Link unprocessable
xpl-20230930_pre.xml Edgar Link unprocessable